Evidence map›Paper›PMID 42830358›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026

Eleven-year population-based evaluation of a regional newborn hearing screening programme.

Andrea Lund, Anita Ekmann Hansen, Louise Devantier

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrea LundDepartment of Oto-Rhino-Laryngology, Head and Neck Surgery, Aarhus University Hospital, Aarhus N, Palle Juul-Jensens Boulevard 167, 8200, Aarhus, Denmark. andrealund@clin.au.dk.ORCID http://orcid.org/0000-0002-7016-097X
Anita Ekmann HansenDepartment of Oto-Rhino-Laryngology, Head and Neck Surgery, Aarhus University Hospital, Aarhus N, Palle Juul-Jensens Boulevard 167, 8200, Aarhus, Denmark.
Louise DevantierDepartment of Oto-Rhino-Laryngology, Head and Neck Surgery, Aarhus University Hospital, Aarhus N, Palle Juul-Jensens Boulevard 167, 8200, Aarhus, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUniversal newborn hearing screening (UNHS) is widely implemented, but long-term population-based evaluations of programme performance remain limited. This study aimed to evaluate long-term performance of a regional UNHS programme over an 11-year period, focusing on screening coverage, referral rates, and diagnostic outcomes across screening modalities.

methodsThis retrospective population-based cohort study included all live-born infants in the Central Denmark Region from 2015 to 2025. Screening pathways were categorised in three groups: automated auditory brainstem response (AABR)-only screening for infants without recognised risk factors, combined AABR and otoacoustic emissions (OAE) screening for infants with recognised risk factors, and a group in which only OAE screening was recorded. Programme outcomes included screening coverage, primary referral rate, final referral rate to diagnostic auditory brainstem response (D-ABR), and diagnostic yield.

resultsAmong 160,719 live-born infants, 157,849 (98.2%) underwent screening. Overall, 5,070 infants (3.2%) were referred after primary screening. Primary referral rates were 0.2% for AABR-only screening and approximately 15% for OAE-based screening pathways (p < 0.001). Of referred infants, 85.5% achieved bilateral pass at audiological rescreening, and only 732 infants (0.46% of screened infants) proceeded to D-ABR. Among these, 417 had confirmed hearing loss (diagnostic yield 57.1%).

conclusionThe programme demonstrated stable long-term performance with high screening coverage and low final referral rates within a structured, risk-adapted screening model. AABR-based screening in non-risk infants was associated with a very low primary referral rate while maintaining diagnostic yield. These findings support the use of AABR as a primary screening modality within structured UNHS programmes.

Indexed as

Automated auditory brainstem responseHearing lossNewborn hearing screeningOtoacoustic emissionsScreening referral rates

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.